Sean Wuxiong Cao Sells $79.9K of NovaBridge Biosciences (NBP) — SEC Form 4, Sep 11, 2026
Open-Market Net Sale · SEC Form 4
−$79,904
Equity position changed by -28.8%
Equity Position
266K sh
374,445 → 266,467
Equity Change
-28.8%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Sean Wuxiong Cao CIK 0002109966 |
Officer
|
Sean Wuxiong Cao at NovaBridge Biosciences
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$122,488
More from this insider at NovaBridge Biosciences
| 2026-09-08 | Exercise | — | View |
| 2026-06-24 | Award | — | View |
| 2026-05-18 | Sell | -$42,584 | View |
Non-Derivative Securities Transactions
Footnotes (4)
- F1
- The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer. Show more
- F2
- The Reporting Person sold 46,947 ADSs representing approximately 107,978 ordinary shares in connection with the partial vesting of a restricted stock unit award on September 3, 2026, solely to satisfy tax withholding obligations incurred in connection with the vesting. Show more
- F3
- Reported securities are represented by 46,947 ADSs. Show more
- F4
- Reported sales price represents the converted sales price of the ADSs of $1.6908. Show more
Related filings at NovaBridge Biosciences
Institutional Holders
13F holders · Sep 30, 2026
47
institutional managers reporting a position
Largest by reported value
- Hhlr Advisors, Ltd. $8.16M
- Morgan Stanley $4.74M
- Aihc Capital Management Ltd $3.93M
5%+ Holders · 13D/G
3 filers
-
Hhlr Advisors, Ltd. 4.9%
Other insiders at NovaBridge Biosciences
GET /v1/forms/4/0002109966-26-000008
API docs
View Original SEC Filing